top of page

FDA Regulatory Strategy

E22 General Considerations for Patient Preference

Clinical Data Presentations for Orthopedic Device Applications

Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency

Post-Market Clinical Follow-up (PMCF)

In Silico Trials: Transforming Medical Device Development Through Digital Innovation

FDA Breakthrough Device Designation: Accelerating Innovation in Medical Technology

Receiving an FDA AINN Letter

The Strategic Edge in FDA Submissions: Applying "Least Burdensome"

Understanding the Content of Premarket Submissions for Device Software Functions

What is MDR? Understanding Medical Device Regulation Compliance

FDA Q-Submission Program 2025: What Medical Device Innovators Need to Know

Trial Design and Methodology

Randomization and Kit Lists: What They Are and Why They Matter

Multiple Endpoints in Clinical Trials: Why Medical Device Manufacturers Can't Afford to Ignore Multiplicity

The Critical Role of Radiographic Data in Medical Device Clinical Trials

The Role of DMCs

Clinical Events Committees (CEC)

Why are inclusion criteria important?

What is a DSMB?

E9 Statistical Principles for Clinical Trials: The Foundation of Regulatory Success

What is a Composite Endpoint?

Primary vs Secondary vs Exploratory: Building the Right Endpoint Hierarchy for FDA Success

Beyond the Data: The Strategic Role of Clinical Outcome Assessments in Regulatory Success

To Be or Not To Be Covariate Adjusted

E9(R1) Addendum: Estimands & Sensitivity Analysis in Medical Device Trials

Non-Inferiority (NI) Trial Design Strategy

Data and Statistical Methods

Does sleep apnea affect heart rate variability during wakefulness?

Do you know how a transition in EHR can impact the patient experience?

What genes affect sleep?

Do you know that many aspects of sleep and circadian behavior are heritable?

We share your passion.

How Do We Conduct Long-Term Studies to Show Efficacy of CPAP?

The 10 Largest Clinical Research Organizations (CROs)

Transition planning from another CRO

Overview of Building 66 at the FDA White Oak Campus

When to hire a biostatistics CRO vs. doing it in-house

10 Medium-Sized CROs in North America

CROs & Venture Capital: Accelerating Biotech Innovation

Private Equity Bought Your Sponsor.

The Best Small CRO for Biostatistics and FDA Submissions — Proven Since 1986

Industry Landscape

E2D(R1) Postapproval Safety Data

M14 General Principles on Planning, Designing, Analyzing, and Reporting of Non-interventional Studies That Utilize Real-World Data for Safety Assessment of Medicines

E22 General Considerations for Patient Preference

Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products 

Cuffless Non-invasive Blood Pressure Measuring Devices – Clinical Performance Testing and Evaluation

Use of Real-World Evidence

Clinical Data Presentations for Orthopedic Device Applications

ISO 11979-7:2024

Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency

What Is the EMA

BSC team publishes new article on Propensity Score Design

ICPE 2023: The Global Home for the Science of Real-World Evidence

Randomization and Kit Lists: What They Are and Why They Matter

Multiple Endpoints in Clinical Trials: Why Medical Device Manufacturers Can't Afford to Ignore Multiplicity

Does sleep apnea affect heart rate variability during wakefulness?

Do you know how a transition in EHR can impact the patient experience?

What genes affect sleep?

BSC's Brendan Keenan co-authors paper on Obstructive Sleep Apnea (OSA)

Effect of Obstructive Sleep Apnea on cardiac remodeling in Nonobese and Obese adults

Do you know that many aspects of sleep and circadian behavior are heritable?

The Critical Role of Radiographic Data in Medical Device Clinical Trials

The Role of DMCs

BSC® participates in three FDA orthopedic panels

Clinical Events Committees (CEC)

We share your passion.

Why are inclusion criteria important?

Two abstracts have been accepted for presentation at the 2021 SLEEP annual meeting

Post-Market Clinical Follow-up (PMCF)

What is a DSMB?

In Silico Trials: Transforming Medical Device Development Through Digital Innovation

FDA Breakthrough Device Designation: Accelerating Innovation in Medical Technology

E9 Statistical Principles for Clinical Trials: The Foundation of Regulatory Success

David Maislin and colleagues publish paper on Adjuvant during single-level partial discectomy in patients with severe leg and back pain

Heritability of fat distributions in male mice

A Comprehensive Overview of CDISC

You have missing data.

How Do We Conduct Long-Term Studies to Show Efficacy of CPAP?

The 10 Largest Clinical Research Organizations (CROs)

Receiving an FDA AINN Letter

What is a Composite Endpoint?

Beyond the Code

Transition planning from another CRO

Primary vs Secondary vs Exploratory: Building the Right Endpoint Hierarchy for FDA Success

The Strategic Edge in FDA Submissions: Applying "Least Burdensome"

Overview of Building 66 at the FDA White Oak Campus

Understanding the Content of Premarket Submissions for Device Software Functions

When to hire a biostatistics CRO vs. doing it in-house

Beyond the Data: The Strategic Role of Clinical Outcome Assessments in Regulatory Success

FDA Posts Proposal To Amend QMS Regulations To Incorporate ISO 13485

10 Medium-Sized CROs in North America

CROs & Venture Capital: Accelerating Biotech Innovation

To Be or Not To Be Covariate Adjusted

What is MDR? Understanding Medical Device Regulation Compliance

BSC founder appears on healthcare technology podcast

BSC participates in the European Sleep Research Meeting

FDA Q-Submission Program 2025: What Medical Device Innovators Need to Know

Private Equity Bought Your Sponsor.

BSC's David Maislin co-authors paper on CT-based measurements

E9(R1) Addendum: Estimands & Sensitivity Analysis in Medical Device Trials

The Best Small CRO for Biostatistics and FDA Submissions — Proven Since 1986

Non-Inferiority (NI) Trial Design Strategy

Knowledge Base

Sharp thinking on biostatistics, regulation, and the industry.

BSC® Differentiator

What Sets us Apart

Submission Grade Experience

Regulatory-first biostatistics

Support built specifically for FDA-facing programs, from early feasibility through submission and post-market requirements.

Direct communication, faster turn around

Our biostatisticians write the SAP and run the analysis. One person owns both — no separate programmer, no project manager in between.

Versatile Solutions

Engage us for a focused analysis or a full submission, We size the work to the problem.

Proven FDA Experience

Hands-On FDA Pathways, statistical reviews, and regular interactions, reducing risk and rework.

bottom of page